Ariadne Wealth Management »

Neurocrine Biosciences shares owned by Ariadne Wealth Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Ariadne Wealth Management from 13F filings

Historical chart of Ariadne Wealth Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Ariadne Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Ariadne Wealth Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $222k 1.9k 118.80
2024-09-30 $205k 1.7k 123.98

More positions owned by Ariadne Wealth Management

Ishares Silver Tr Ishares (SLV)
Dimensional Etf Trust Us Mktwide Value (DFUV)
American Centy Etf Tr Us Eqt Etf (AVUS)
Blackrock Etf Trust Ii Ishares Short-te (CALI)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Spdr Gold Tr Gold Shs (GLD)
Dimensional Etf Trust Us Equity Market (DFUS)
Ishares Tr Ultra Short Dur (ICSH)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Internatnal Val (DFIV)
Broadcom (AVGO)

View all positions for Ariadne Wealth Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Morgan Stanley
Wellington Management Company
Bellevue Group
Thomas Stevens, CFA"
Deerfield Management Company
Rtw Investments
Millennium Management

View all funds holding Neurocrine Biosciences